PUB_ID,VISIT,AEPAGENUM,AEDIAG,AEMDVER,AESOC,AEMDRA,LL_NAME,HL_NAME,HLG_NAME,AEONDATE,AESEVE,AESEVE_TXT,AEREL,AEREL_TXT,AEDRAD,AEDRADC,AEOUTC,AEOUTCC,AEOCDATE,AETREATMENT,AEICHC,AEDAIDS,AEDAIDSC,AEVISIT,AESAERCT,AESAERCTC
140-906780,6,1,Cellulitis - left wrist,26.1,Infections and infestations,Cellulitis,Cellulitis of hand,Bacterial infections NEC,Bacterial infectious disorders,22717,2,Grade 2 (Moderate),2,Not related,98,Not Applicable,1,Continuing,22761,None,No,2,No,6,2,No
140-554146,4,1,Upper Respiratory Infection,26.1,Infections and infestations,Upper respiratory tract infection,Upper respiratory infection,Upper respiratory tract infections,Infections - pathogen unspecified,22622,1,Grade 1 (Mild),2,Not related,98,Not Applicable,1,Continuing,22629,Medication,No,2,No,4,2,No
140-165610,7,1,Ear infection,26.1,Infections and infestations,Ear infection,Ear infection,Ear infections,Infections - pathogen unspecified,22758,2,Grade 2 (Moderate),2,Not related,98,Not Applicable,1,Continuing,22762,Medication,No,2,No,7,2,No
140-165610,9,2,Covid 19 infection,26.1,Infections and infestations,COVID-19,COVID-19,Coronavirus infections,Viral infectious disorders,22802,1,Grade 1 (Mild),2,Not related,98,Not Applicable,1,Continuing,22809,None,No,2,No,9,2,No
140-383526,9,1,COVID-19 infection,26.1,Infections and infestations,COVID-19,COVID-19,Coronavirus infections,Viral infectious disorders,22836,2,Grade 2 (Moderate),2,Not related,98,Not Applicable,1,Continuing,22840,Medication,No,2,No,9,2,No
140-725391,5,1,Upper respiratory infection,26.1,Infections and infestations,Upper respiratory tract infection,Upper respiratory infection,Upper respiratory tract infections,Infections - pathogen unspecified,22717,1,Grade 1 (Mild),2,Not related,98,Not Applicable,1,Continuing,22727,Medication,No,2,No,5,2,No
140-443924,4,1,Infusion site rash,26.1,General disorders and administration site conditions,Infusion site rash,Infusion site rash,Infusion site reactions,Administration site reactions,22699,3,Grade 3 (Severe),1,Related,98,Not Applicable,1,Continuing,22721,None,No,2,No,4,2,No
140-443924,9,2,Gastroenteritis,26.1,Infections and infestations,Gastroenteritis,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,22858,2,Grade 2 (Moderate),2,Not related,98,Not Applicable,1,Continuing,22862,Medication,No,2,No,9,2,No
140-585463,7,6,Upper respiratory Infection,26.1,Infections and infestations,Upper respiratory tract infection,Upper respiratory infection,Upper respiratory tract infections,Infections - pathogen unspecified,22732,2,Grade 2 (Moderate),2,Not related,98,Not Applicable,1,Continuing,22742,Medication,No,2,No,7,2,No
140-511886,2,2,Erythema at the study product administration site,26.1,General disorders and administration site conditions,Administration site erythema,Administration site erythema,Administration site reactions NEC,Administration site reactions,22685,1,Grade 1 (Mild),2,Not related,98,Not Applicable,1,Continuing,22686,None,No,2,No,2,2,No
140-511886,7,1,COVID-19,26.1,Infections and infestations,COVID-19,COVID-19,Coronavirus infections,Viral infectious disorders,22761,2,Grade 2 (Moderate),2,Not related,98,Not Applicable,1,Continuing,22776,Medication,No,2,No,7,2,No